Last updated on July 2018

Biomarker-based Study in R/M SCCHN


Brief description of study

This is a biomarker-driven trial that will enroll patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing after first-line platinum-based chemotherapy. Based on potential biomarkers and molecular alterations identified in the biopsy from the central platform, patients will be allocated in different cohorts. There will be biomarker-positive patient cohorts and immunotherapy cohorts.

Clinical Study Identifier: NCT03088059

Contact Investigators or Research Sites near you

Start Over

EORTC HQ

Universitair Ziekenhuis Gent
Gent, Belgium
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.